Skip to main content

Main menu

  • About
    • Our Mission
    • Donors
    • Board of Directors
    • Advisory Boards
    • Staff
    • Careers
    • Who we are
    • FAQ
    • Annual Report
  • Why New TB Drugs?
    • Global Pandemic
    • Inadequate Treatment
    • Antimicrobial Resistance
    • Maternal and Child Health
    • Cycle of Poverty
  • R&D
    • Scientific Vision
    • Pipeline
    • Discovery
    • Engaging Communities
  • Access
    • Our Commitment
    • Access in TB Market
    • Child-friendly medicines
    • Pretomanid and BPaL
    • Pathways to Access BPaL
  • News
    • Latest News
    • Publications
    • Voices of TB
    • Research Papers
    • Making an Impact
  • Donate

Search form

Latest News

September 22

UN Commitment on Tuberculosis Needs Leadership to Match Ambition

September 15

Kyrgyzstan, Ukraine, and Uzbekistan Update National Guidelines for Drug-Resistant TB Treatment to Advance National Rollout of Three-Drug, Six-Month Regimen

August 14

Realizing our “Triple-A Mandate”

All News

Voices of TB

Videos from the Global Health Community

Besik's Story of #TBCourage

Fighting the Oldest Pandemic

All Voices

Featured Publication

Advancing Shared Goals

  • Click here to read the full report

All Publications

Research Papers

YES, WE HAVE the POWER to END TB!
Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model
All Papers

For the Press

Press Contact:
Thomas Lynch
p | +1 646 616 8639
e | thomas.lynch@tballiance.org

View the 2022 Annual Report

Navigate

  • About
  • Why New TB Drugs?
  • R&D
  • Access
  • News
  • Donate

New York: 80 Pine Street, 20th floor, New York, NY 10005 • +1 212 227 7540

Pretoria: Boardwalk Office Park, Block 1/Suite 5, 107 Haymeadow Street, Faerie Glen, Pretoria 0043, South Africa • +27 12 991 6328

Visit our South Africa website
Press Inquiries

Jess Wiggs
p | +1 646 616 8613
e | jessica.wiggs@tballiance.org

Jobs

View job openings

Join our mailing list
Interests
© 2023 The TB Alliance. All Rights Reserved. Site by Darby Communications Report a Concern